Geode Capital Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
5,777,269
+1,487,849
+35% +$3.93M ﹤0.01% 2103
2025
Q1
$12.9M Buy
4,289,420
+448,502
+12% +$1.35M ﹤0.01% 2136
2024
Q4
$9.83M Sell
3,840,918
-5,757
-0.1% -$14.7K ﹤0.01% 2387
2024
Q3
$14.3M Sell
3,846,675
-70,819
-2% -$263K ﹤0.01% 2164
2024
Q2
$24.8M Buy
3,917,494
+436,108
+13% +$2.76M ﹤0.01% 1818
2024
Q1
$18.7M Buy
3,481,386
+101,922
+3% +$547K ﹤0.01% 1960
2023
Q4
$17M Buy
3,379,464
+573,281
+20% +$2.88M ﹤0.01% 2014
2023
Q3
$4.74M Buy
2,806,183
+75,731
+3% +$128K ﹤0.01% 2664
2023
Q2
$7.59M Buy
2,730,452
+784,588
+40% +$2.18M ﹤0.01% 2457
2023
Q1
$3.54M Sell
1,945,864
-84,628
-4% -$154K ﹤0.01% 2783
2022
Q4
$10.3M Buy
2,030,492
+108,903
+6% +$552K ﹤0.01% 2253
2022
Q3
$9.55M Buy
1,921,589
+348,755
+22% +$1.73M ﹤0.01% 2296
2022
Q2
$5.85M Buy
1,572,834
+24,819
+2% +$92.3K ﹤0.01% 2616
2022
Q1
$8.68M Sell
1,548,015
-8,586
-0.6% -$48.2K ﹤0.01% 2447
2021
Q4
$9.46M Buy
1,556,601
+40,345
+3% +$245K ﹤0.01% 2477
2021
Q3
$14.8M Buy
1,516,256
+46,560
+3% +$453K ﹤0.01% 2174
2021
Q2
$21M Buy
1,469,696
+805,147
+121% +$11.5M ﹤0.01% 1927
2021
Q1
$15.8M Buy
664,549
+74,788
+13% +$1.78M ﹤0.01% 2029
2020
Q4
$7.86M Buy
589,761
+58,015
+11% +$773K ﹤0.01% 2324
2020
Q3
$3.69M Buy
531,746
+40,518
+8% +$281K ﹤0.01% 2567
2020
Q2
$6.03M Buy
491,228
+169,729
+53% +$2.08M ﹤0.01% 2217
2020
Q1
$925K Buy
321,499
+32,865
+11% +$94.6K ﹤0.01% 3053
2019
Q4
$1.09M Buy
288,634
+27,216
+10% +$103K ﹤0.01% 3252
2019
Q3
$318K Hold
261,418
﹤0.01% 3626
2019
Q2
$266K Sell
261,418
-79,951
-23% -$81.4K ﹤0.01% 3703
2019
Q1
$539K Buy
341,369
+12,492
+4% +$19.7K ﹤0.01% 3412
2018
Q4
$381K Buy
328,877
+8,961
+3% +$10.4K ﹤0.01% 3472
2018
Q3
$1.18M Buy
319,916
+19,809
+7% +$73.3K ﹤0.01% 3148
2018
Q2
$918K Buy
300,107
+12,518
+4% +$38.3K ﹤0.01% 3221
2018
Q1
$1.12M Buy
287,589
+3,359
+1% +$13.1K ﹤0.01% 3070
2017
Q4
$1.28M Buy
284,230
+8,386
+3% +$37.6K ﹤0.01% 2998
2017
Q3
$1.51M Sell
275,844
-15,657
-5% -$85.8K ﹤0.01% 2906
2017
Q2
$2.21M Buy
291,501
+34,802
+14% +$264K ﹤0.01% 2675
2017
Q1
$911K Buy
256,699
+18,685
+8% +$66.3K ﹤0.01% 3061
2016
Q4
$1.36M Buy
238,014
+6,391
+3% +$36.5K ﹤0.01% 2840
2016
Q3
$1.8M Buy
231,623
+132,626
+134% +$1.03M ﹤0.01% 2626
2016
Q2
$615K Buy
98,997
+10,632
+12% +$66K ﹤0.01% 3129
2016
Q1
$726 Buy
88,365
+2,998
+4% +$25 ﹤0.01% 3047
2015
Q4
$1.48M Buy
85,367
+12,439
+17% +$216K ﹤0.01% 2665
2015
Q3
$835K Buy
+72,928
New +$835K ﹤0.01% 2965